ACUTE PANCREATITIS
Clinical trials for ACUTE PANCREATITIS explained in plain language.
Never miss a new study
Get alerted when new ACUTE PANCREATITIS trials appear
Sign up with your email to follow new studies for ACUTE PANCREATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for severe pancreatitis in early trial
Disease control CompletedThis study tested a new medicine called CM4620-IE in 21 people with severe pancreatitis and body-wide inflammation (SIRS). The goal was to see if the drug is safe and helps control the disease. Participants received either the drug plus standard care or standard care alone. The s…
Matched conditions: ACUTE PANCREATITIS
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New drug shows promise for speeding recovery in pancreatitis patients
Symptom relief CompletedThis study tested a drug called Auxora in 216 people with acute pancreatitis and a related body-wide inflammation (SIRS). Participants received either Auxora or a placebo for three days. The main goal was to see if the drug helped patients tolerate solid food sooner. The trial ai…
Matched conditions: ACUTE PANCREATITIS
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Symptom relief
Last updated May 07, 2026 18:40 UTC
-
Blood clot clues may predict pancreatitis severity
Knowledge-focused CompletedThis study looked at how blood clotting changes in people with acute pancreatitis. Researchers took blood samples from 141 patients over several days to measure markers of clotting and inflammation. The goal was to see if these markers could help predict whether the disease would…
Matched conditions: ACUTE PANCREATITIS
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC